The effects of a new adrenergic antagonist on the mesenteric circulation.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005021:Ethylamines / Q000494:pharmacology; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D008638:Mesenteric Arteries / Q000187:drug effects; D008643:Mesentery / Q000098:blood supply* / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D010656:Phenylephrine / Q000037:antagonists & inhibitors; D011433:Propranolol / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects*; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000037:antagonists & inhibitors*; D014655:Vascular Resistance / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D005021:Ethylamines; D009946:Organothiophosphorus Compounds; D013565:Sympatholytics; D013566:Sympathomimetics; D010656:Phenylephrine; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine